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Background: The mammalian inner ear contains sensory organs, the organ of Corti in the cochlea and cristae and
maculae in the vestibule, with each comprised of patterned sensory epithelia that are responsible for hearing and
balance. The development, cell fate, patterning, and innervation of both the sensory and nonsensory regions of the
inner ear are governed by tight regulation involving, among others, transcription factors and microRNAs (miRNAs).
In humans, mutations in specific miRNA genes are associated with hearing loss. In mice, experimental reduction or
mutations of miRNAs in the inner ear leads to severe developmental and structural abnormalities. A comprehensive
identification of miRNAs in the sensory epithelia and their gene targets will enable pathways of auditory and
vestibular function to be defined.
Results: In this study, we used Next-Generation Sequencing (NGS) to identify the most prominent miRNAs in the
inner ear and to define miRNA-target pairs that form pathways crucial for the function of the sensory epithelial cells.
NGS of RNA from inner ear sensory epithelial cells led to the identification of 455 miRNAs in both cochlear and
vestibular sensory epithelium, with 30 and 44 miRNAs found in only cochlea or vestibule, respectively. miR-6715-3p
and miR-6715-5p were defined for the first time in the inner ear. Gene targets were identified for each of these
miRNAs, including Arhgap12, a GTPase activating protein, for miR-6715-3p, implicating this miRNA in sensory hair
cell bundle development, actin reorganization, cell adhesion and inner ear morphogenesis.
Conclusions: This study provides a comprehensive atlas of miRNAs in the inner ear sensory epithelia. The results
provide further support of the essential regulatory role of miRNAs in inner ear sensory epithelia and in regulating
pathways that define development and growth of these cells.
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miRNAs play an essential role in inner ear development
[1]. miRNAs are small non-coding RNAs that regulate
gene expression post-transcriptionally. By binding to se-
quences in the 3’ untranslated region (UTR) of mRNAs, a
miRNA can inhibit target mRNAs by translational suppres-
sion and mRNA destabilization [2]. miRNAs have been im-
plicated in hearing loss in humans, since mutations in the* Correspondence: karena@post.tau.ac.il
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unless otherwise stated.seed region of miR-96 or its gene are associated with hear-
ing loss in three extended families [3,4]. miRNAs were
also reported in other human ear pathologies, including
an elevation of miR-21 in cholesteatomas [5] and in ves-
tibular schwannomas [6]. miRNAs were found to regulate
the otitis media inflammatory response [7]. Their study in
humans, however, has been hampered by the unavailabil-
ity of inner ear RNA from human subjects, making the
mouse an invaluable model for studying miRNA develop-
ment and regulation in the inner ear [8]. In an ENU-
induced mutant mouse exhibiting deafness and vestibular
dysfunction, a mutation in the miR-96 seed region was
found to be responsible for hearing loss, presumably duel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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direct and indirect gene targets [9]. A number of mouse
mutants affecting miRNA regulation through Dicer have
been created, leading to developmental inner ear defects
[10,11]. These conditional knock-out mouse mutants have
been instrumental in demonstrating that miRNAs are vital
for inner ear morphogenesis and development of the sen-
sory epithelia and sensory neurons.
Expression of over 300 miRNAs have been reported in
mouse and rat inner ears thus far, identified by micro-
array analysis [8,10,12,13], with the majority of work per-
formed on the triad mir-96, −182, and −183 [14]. In
order to further identify and characterize miRNAs in the
mammalian inner ear, we used NGS for the first time to
identify miRNAs in cochlear and vestibular sensory epi-
thelia. Using this method, we identified over 500 inner
ear miRNAs, both in common between and unique to
each tissue. We further validated and characterized the
expression of two miRNAs, miR-6715-3p and miR-6715-
5p, in the mouse inner ear. Vezatin, an adherens junc-
tions transmembrane protein previously implicated in
deafness [15] and Arhgap12, a Rho GTPase activating
protein [16], were verified to be gene targets of miR-
6715-3p. Protocadherin 19, a member of the δ2 subclass
of nonclustered protocadherins and associated with epi-
lepsy and mental retardation [17], is a gene target of
miR-6715-5p. Arhgap12, newly described in the inner
ear, is expressed in the epithelial cell-cell junctions of
the hair and supporting cells. The miR-6715-3p–Arhgap12
miRNA target pair defines a new regulatory pathway. Un-
derstanding these interactions may shed light on known
and novel miRNAs, their effect on the development of
normal and impaired hearing, and the mechanisms lead-
ing towards deafness.
Results
RNA-seq derived miRNA transcription profile of the
mouse inner ear sensory epithelium
In order to identify miRNAs in the auditory and vestibu-
lar sensory epithelium, we sequenced short RNA mole-
cules from cochlear and vestibular sensory epithelia by
high–throughput RNA sequencing (RNA-seq). For the
cochlea, the sensory epithelium consisted of the organ of
Corti, including hair cells, supporting cells, and cells of
the greater and lesser epithelial ridges, as well as mesen-
chymal and neuronal cells. For the vestibule, the sensory
epithelium was derived from the saccule, utricle and the
lateral and anterior cristae and included hair cells and
supporting cells. The advantage of using high–throughput
sequencing is that this technique allows for assessment of
transcript expression in a given sample at a large dynamic
range, from minute quantities to highly abundant ones,
and does not require a-priori knowledge for the identifica-
tion of modified and novel RNA molecules in addition toknown ones. cDNA libraries from small RNAs were pre-
pared from dissected sensory epithelium of post-natal day
(P)0 mice. Subsequent analysis of sequence reads was
done using miRNAkey, a tool for miRNA differential ex-
pression analysis [18]. Processed reads were aligned to the
mature Mus musculus miRNA database (http://www.mir
base.org), allowing one mismatch to occur between a read
and the reference, due to isomiRs [19]. Sixty-six and
61.4% of the total reads from cochlear and vestibular sen-
sory epithelia, respectively, were aligned to known mouse
miRNAs, indicating a successful isolation of miRNAs. The
majority of mapped reads in cochlear and vestibular sen-
sory epithelia, 96.9% in the cochlea and 97.6% in the vesti-
bule, were uniquely mapped to a single miRNA. Overall,
485 and 499 known miRNAs had an RPM (reads per mil-
lion) mapping higher than 1 in the cochlear and vestibular
sensory epithelium, respectively (Additional file 1: Table S1).
These lists include all miRNAs that have been studied
thus far in the mouse inner ear sensory epithelia, as well
as miRNAs that have not been previously detected. Nine
miRNAs were most highly expressed in the cochlea and
the vestibule, with a similar order in both, except for
miR-204-5p, which was the fourth most prevalent in the
cochlea and the lowest in the vestibule (Table 1).
Differential expression among the known miRNAs was
inferred by miRNAkey, based on the widely-accepted as-
sumption that the number of reads mapped to each
miRNA is relative to its level of expression [20,21]. The
reads numbers in each sample were normalized to RPM
values, and the relative expression levels of the different
miRNAs in the two samples were calculated. In general,
miRNA expression was similar in the cochlear and ves-
tibular sensory epithelia. The majority of miRNAs with
RPM > 1 were found in both tissues (455, or 86%), with
30 found only in the cochlea and 44 found only in the
vestibule (Figure 1A, Additional file 1: Table S1). The
rates of the highest expressing miRNAs in each tissue
were also highly similar between tissues (Pearson coeffi-
cient = 0.99; P < 10−8) (Figure 1B). We defined a miRNA
as differentially expressed if the fold change between
samples was higher than 4 and P < 10−4 (Bonferroni cor-
rected). Eleven miRNAs were differentially expressed in
cochlear and vestibular sensory epithelia (Table 2).
Targets for most highly expressed miRNAs
miRNAs and targets exert their function through regu-
lation of biological processes. As each miRNA can have
multiple targets, we performed an analysis to discover
additional mRNA genes that are computationally pre-
dicted to be targets of the three most highly expressed
miRNAs, miR-182, miR-181a and miR-26a. Among nu-
merous predictions, a few were of particular interest
due to their involvement in auditory function. The tar-
gets were defined according to their presence in the list
Table 1 Most highly expressed miRNAs in cochlear and vestibular sensory epithelium
miRNA name preMir Read count in cochlear sample Cochlea RPM Read count in vestibular sample Vestibule RPM
mmu-miR-182-5p mmu-mir-182 2421025 453713.969 2746404 485527.023
mmu-miR-181a-5p mmu-mir-181a 809893 151778.593 661755 116989.320
mmu-miR-26a-5p mmu-mir-26a 254545 47703.193 243220 42998.001
mmu-miR-204-5p mmu-mir-204 129332 24237.559 84716 14976.641
mmu-miR-27b-3p mmu-mir-27b 110796 20763.806 141616 25035.790
mmu-let-7f-5p mmu-let-7f 86534 16216.968 103956 18378.013
mmu-miR-127-3p mmu-mir-127 85466 16016.819 131667 23276.942
mmu-miR-22-3p mmu-mir-22 80333 15054.865 92772 16400.833
mmu-miR-183-5p mmu-mir-183 79665 14929.678 94421 16692.354
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Genome Informatics (MGI) (http://www.informatics.
jax.org/diseasePortal/) database and predicted by two
prediction algorithms, TargetScanMouse and miRanda
(Table 3). All miRNA targets presented are involved in
auditory function and hearing loss. As a few of the pre-
dicted targets overlap, we postulated that there might be
underlying regulatory networks prompted by these miR-
NAs. This was further illustrated using gene ontology
(GO) of biological-based processes, performed by gene-
MANIA (http://www.genemania.org), where 6/16 genes
fell in the categories ‘sensory perception of sound’ and
‘sensory perception of mechanical stimulus,’ while 5/16Figure 1 miRNA expression similarity in the cochlear and vestibular s
ear miRNAs. High similarity of miRNA expression in the cochlear and vestib
529 miRNAs, expressed with an RPM > 1, in both tissues. B. The relative pro
each tissue. The total amount (100%) represents the sum of RPK values of e
of this total. Each miRNA is color-coded and indicated in the legend.genes fell in the categories ‘inner ear development’ and
‘ear development’ (Additional file 2: Table S2). These
predictions may set the basis for signaling pathways in
the inner ear, subject to experimental validation.
Identification of inner ear miRNAs
In order to identify inner ear miRNAs, the genes associated
with “impaired hearing” (MP:0006325) and “deafness”
(MP:0001967) were downloaded from MGI (Additional file 3:
Table S3). Since these genes are crucial for inner ear de-
velopment and function, we predicted that miRNAs that
reside in their introns may have a role in the inner ear.
Out of the hearing associated genes, ten had pri-miRNAsensory epithelia. A. Tissue similarity and common expression of inner
ular sensory epithelium can be observed with the majority (455) of the
portion of each miRNA among the most highly expressed miRNAs in
ach miRNA. The Y-axis represents the proportion of each miRNA out




















mmu-miR-1298-5p 156 29.235 3202 566.070 19.363 0.052 2731.789 0.00E + 00 0.00E + 00
mmu-miR-375-3p 665 124.625 8837 1562.262 12.536 0.080 6909.886 0.00E + 00 0.00E + 00
mmu-miR-211-5p 234 43.853 2696 476.616 10.869 0.092 2026.071 0.00E + 00 0.00E + 00
mmu-miR-1298-3p 16 2.998 116 20.507 6.839 0.146 73.212 0.00E + 00 0.00E + 00
mmu-miR-135b-5p 216 40.480 1059 187.217 4.625 0.216 529.336 0.00E + 00 0.00E + 00
mmu-miR-10b-5p 2584 484.256 12231 2162.275 4.465 0.224 5963.760 0.00E + 00 0.00E + 00
mmu-miR-6240 54 10.120 249 44.020 4.350 0.230 118.741 0.00E + 00 0.00E + 00
mmu-miR-3059-5p 11 2.061 60 10.607 5.145 0.194 32.292 1.33E-08 1.17E-05
mmu-miR-153-3p 933 174.850 175 30.938 0.177 5.652 541.720 0.00E + 00 0.00E + 00
mmu-miR-383-5p 660 123.688 95 16.795 0.136 7.365 437.013 0.00E + 00 0.00E + 00
mmu-miR-6715-5p 78 14.618 12 2.121 0.145 6.890 50.139 1.43E-12 1.27E-09
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miRNA, expressed in both cochlear and vestibular sensory
epithelia with an RPM> 1, was found in the intron of
deafness-related gene β-tectorin (Tectb) (Figure 2A),
which is expressed in the mouse inner ear and associated
with altered hearing [22]. This pri-miRNA produces
two mature miRNAs, miR-6715-3p and miR-6715-5p
(Figure 2B). These miRs were supported by 2.08 and 5.06
reads per million library reads, respectively (Figure 2C).
These miRs were also found in an analysis of sequences
from mouse data sets derived from different tissues [23].
Provisional ID chr19_45771, available on miRBase (miR-
6715; MI0025026), was detected by an extremely low
number of reads (0.0021-0.0126 per million library reads)
in oocytes, embryonic day (E)7.5 embryo, E15.5 brain,
hippocampus, heart, skin, muscle cells, lung and liver by
RNA-seq.
Expression of new inner ear miRNAs
The expression of miR-6715a-3p and miR-6715a-5p, de-
tected by RNA-seq, was validated by qRT-PCR analysis
(Figure 3A). We found both miRNAs to be expressed in
the sensory epithelium of the mouse cochlea, at E16, P0
and P8. The expression of both miRNAs was dynamic
and increased with age, showing higher expression at
P8 compared to P0 and E16, and at P0 compared to
E16 (P < 0.005). The two miRNAs were undetected in
brain, liver, kidney and heart. This is consistent withTable 3 Predicted mRNA targets for the most abundant
miRNAs in the sensory epithelia of the inner ear
miRNA Targets
miR-182 Bdnf, Ednrb, Rdx, Rere, Sox2
miR-181a Chd7, Grid1, Psap, Slc19a2, Tnfrsf11b
miR-26a Atf2, Fbxo11, Gabrb3, Kcnq4, Rb1, Rere, Slc12a2, Slc19a2the previous RNA-seq detection [23]. The inner ear ex-
pression, and the absence or very low expression of the
miRNAs in other tested tissues, suggests that they are
inner ear-specific miRNAs. The expression prior to the
onset of hearing suggests a developmental role for
these miRNAs.
In order to explore the spatial expression pattern of
the two inner ear miRNAs, in situ hybridization analysis
was performed on inner ears derived from P0 C57/BL6
mice, at the same age the RNA-seq was performed. Con-
sistent with the qRT-PCR results, expression of the two
miRNAs was observed in P0 mice (Figure 3B). A clear
staining of both miRNAs was observed in many parts of
the inner ear, in spiral and vestibular ganglia, basilar
membrane and Reissner's membrane, the stria vascularis
and spiral ligament. In a higher magnification, in the
cochlea, expression of both miRNAs was observed in
the organ of Corti, in the spiral limbus and in particular
in the hair and supporting cells. In the vestibular system,
staining was observed in sensory epithelia of the saccule
and the utricle, in hair and supporting cells.Target pathways in auditory and vestibular function
In order to determine what pathway might be impacted
by miR-6715-3p and miR-6715-5p regulation, we searched
for potential targets. Targets were predicted by TargetScan
Custom, which searches for a complementary 3’UTR
given a putative seed sequence. miR-6715-3p and miR-
6715-5p were each predicted to target 201 and 206 targets,
respectively, with ten overlapping targets (Additional file 5:
Table S5). We examined which potential targets were inner
ear-expressing genes, genes associated with hearing loss in
human or mice, or genes encoding proteins involved in
pathways relevant for inner ear function. These included
protocadherin 19 (Pcdh19) [24] as a candidate target for
Figure 2 The genomic location, predicted structure and relative level of expression of miR-6715-3p and miR-6715-5p. A. pre-miR6715 is
located in the second intron of the Tectb gene. B. miRDeep2 prediction of the RNA secondary hairpin structure of the unprocessed miR-6715-3p,
miR-6715-5p, and loop. The seed region of miR-6715-3p is indicated in blue and of miR-6715-5p in green. C. Middle density plot shows the
distribution of reads in the predicted precursor sequence, as produced by miRDeep2.
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Arhgap12 [16] as candidate targets for miR-6715-3p.
To test whether these potential targets have a direct
interaction with miR-6715-3p and miR-6715-5p, we
examined luciferase activity by inserting the 3’UTR of
the potential targets downstream of a luciferase gene.
Transfections of these constructs, together with a pre
miR-6715 expressing vector into HEK293T cells, and meas-
urement of the relative luciferase activity compared to a
mutant 3’UTR construct, were indicative of targeting.
Pcdh19 was found to be a direct target of miR-6715a-5p
(Figure 4A), with a reduction of luciferase activity by ap-
proximately 35%. Vezt and Arhgap12 were found to be
direct targets of miR-6715-3p, with a reduction of lucifer-
ase activity by 55% and 15%, respectively (Figure 4B, C).
Snc8a is not a direct target of miR-6715a-3p, as luciferase
activity was not reduced (Figure 4D).
Arhgap12 was chosen for further analysis, due to its
putative role as a GTPase activating protein (GAPs) forsmall G proteins and expression in epithelial cell–cell
junctions [16]. Temporal expression of Arhgap12 mRNA
was evaluated by qRT–PCR in the cochlear sensory epi-
thelium. In the cochlea, Arhgap12 was expressed at E16,
P0 and P8, with a small, though not significant, increase
in age (Figure 5). This protein was not previously char-
acterized in the inner ear. We found Arhgap12 expres-
sion, using a commercial antibody examined for
specificity by peptide competition (Additional file 6) in
the organ of Corti, in hair and supporting cells, the stria
vascularis, spiral ligament and Reissner’s membrane
(Figure 6A, B). The strongest expression was observed
in nerve cells, in the spiral ganglia (Figure 6C). In the
vestibule, expression was found in the hair and support-
ing cells (Figure 6D). In whole mount preparations, Arh-
gap12 was found to be present in hair and supporting
cells (Figure 7A-C). Its expression was observed in the
same hair cell and cuticular plate planes as ZO-1, but
did not overlap (Figure 7A-C). The outer hair cell and
Figure 3 miR-6715-3p and miR-6715-5p expression in the inner ear. A. qRT-PCR analysis and validation of novel miRNAs in the mouse
cochlea sensory epithelium. miR-6715-3p and miR-6715-5p exhibited increased expression with age between E16 and P8 (*) P < 0.05, (**)
P < 0.005. n = 5. B. In situ hybridization of P0 mouse cochlear and vestibular sections. miR-6715-3p and miR-6715-5p expression was found in the
hair and supporting cells of both cochlea and vestibule, spiral and vestibular ganglia, stria vascularis, basilar membrane and in Reissner's
membrane. sa, saccule; ut, utricle; sg, spiral ganglia; sm, scala media; st, scala tympani; sv, scala vestibule; ohc, outer hair cells; ihc, inner hair
cells; hc, hair cells. Bar: 100 μm.
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appears absent in these junctions. Arhgap12 appears in
the kinocilium (Figure 6B).Discussion
The function of miRNAs and their targets in the mamma-
lian inner ear are now being discovered, as the link between
miRNAs and hearing and deafness has been established.
The inner ear is a complex tissue with multiple cell types,
with miRNAs involved in fine-tuning the multitude path-
ways required for functional hearing. While there are a
relatively small number of miRNAs in mammals, their
role in regulation far surpasses their number, since each
miRNA can exert its effect on hundreds of downstream
targets [26]. Hundreds of miRNAs have been discovered
in the inner ear; only a subset of these miRNAs have vali-
dated targets (reviewed in Table 1 [27]).Our study was designed to profile the general expression
of miRNAs in the inner ear and a comparison of the audi-
tory and vestibular epithelia. We chose the time point of
p0 since work by our group [10,13] and others have dem-
onstrated that miRNAs are expressed and functional at
this stage, including miRNA-96, which is essential for
hearing [3,9]. RNA-seq analysis led to the identification of
over 500 miRNAs, with miR-182 as the most highly
expressed miRNA in both sensory epithelia (Table 1) and
accounting for more than 50% of the 20 most highly
expressed miRNAs. A few targets have been confirmed for
miR-182, including Sox2, Clic5 and Tbx1 [28-30]. The
second most abundant miRNA in the cochlear and ves-
tibular sensory epithelia, miR-181a-5p, has no known
validated targets in the inner ear. This miRNA has been
studied in other systems and found to have a pro-
proliferative role in cultured human myeloid leukemia
cells [31] and regulates thymic selection in mouse T-cells
Figure 4 miRNA-target prediction validation and expression. Using TargetScan, potential targets of miR- 6715-3p and miR-6715-5p were
identified, based on the complimentarily of the seed region and 6-7 nt sequence of the target mRNA. To test the possibility of miR-target regulation,
luciferase assays were performed. A. Protocadherin19 as a potential target of miR-6715-5p. Wild-type 3’UTR had approximately 65% of luciferase activity
as compared to the mutant. (*) P < 0.05. B. Vezatin as a potential target of miR-6715-3p. Wild-type 3’UTR had approximately 45% of luciferase activity as
compared to the mutant (*) P < 0.05. C. Activator for the Rho-type GTPases Arhgap12 as a potential target of miR- 6715-3p. Wild-type 3’UTR had
approximately 85% of luciferase activity as compared to the mutant. (*) P < 0.05. D. Scn8a is not a direct target for miR-6715-3p, as the luciferase activity
was not reduced.
Figure 5 qRT-PCR analysis of Arhgap12 expression in the
mouse cochlea sensory epithelia. Arhgap12 exhibited a similar
expression pattern at E16, P0 and at P8 in cochlear sensory epithelia,
with no significant differences between ages. n = 5.
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inner ear, where it has been shown to promote prolifera-
tion [33].
We validated a number of targets for miR-6715-3p
and miR-6715-5p. Predicted targets for the miRNAs de-
scribed in this study have direct or potential implications
for hearing loss. Pcdh19 is expressed in the zebrafish
inner ear [24]. Mutations in protocadherin 19 (PCDH19)
have been associated with X chromosome-linked epilepsy
and mental retardation and it is a member of the proto-
cadherin family of proteins [17]. This family includes pro-
tocadherin 15 (Pcdh15), with a known function in the tip
links of the stereocilia of the inner ear in conjunction with
cadherin 23 [34] and has been associated with multiple
mutations in both non-syndromic and syndromic hearing
loss in humans [35,36].
Vezatin (Vezt) is an adherens junctions transmembrane
protein, and while it is ubiquitously expressed in these
junctions, it is especially prevalent in in hair and support-
ing cells of the mouse inner ear [15]. Vezt mutant mice
Figure 6 Arhgap12 protein expression in mouse inner ear
sections. Immunohistochemistry of Arhgap12 (green) in P0 inner
ear sections, with hair cells stained by myosin VI (red) and nuclei
stained by Draq5 (blue). A. Arhgap12 was detected in the organ of
Corti, in hair and supporting cells, stria vascularis, spiral ligament and
Reissner’s membrane. B. Magnification of the organ of Corti, with
localization of Arhgap12 in epithelial cells. C. Arhgap12 is localized
to the spiral ganglia. D. In the vestibular system, Arhgap12 is present
in hair and supporting cells in the crista. Bar: A, 100 μm; B-D, 50 μm.
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hair cell apoptosis. Most compelling, the resistance of
the organ of Corti to mechanical stress was reduced
when vezatin was absent in the inner ears of conditional
mutants. These studies led to the prediction that veza-
tion is required to maintain junction integrity and is
crucial to protect the junctions from mechanical stress
due to sound trauma.Arhgap12, a Rho GTPase activating protein (GAP)
family member, is a component of cell–cell junctions in
kidney epithelial cells [16]. While not previously known
to be expressed in the inner ear, its target, Rac1, localizes
to hair and supporting cells, specifically in the stereocilia
and kinocilium of the hair cells. It was found to be in-
volved in hair cell morphogenesis, specifically in hair
bundle development, epithelia actin assembly and cell
adhesion. Inactivation of Rac1 specifically in the otic epi-
thelium leads to defects in cochlear morphogenesis, hair
bundle orientation and cellular organization of the organ
of Corti [37]. Arhgap12 was found to target Rac1 and in-
activates it by increasing GTP hydrolysis [38]. Here we
suggest a key role for miR-6715-3p in targeting Arha-
gap12 and in this fashion, influencing Rac1 in the inner
ear (Figure 8).
Arhgap12, a GAP protein, is involved in controlling
the time period in which Rac1 will remain active. In
MDCK cells, Arhgap12 expression overlaps with Rac1
expression [38,39], probably due to the regulation of
Arhgap12 on Rac1 at this time point. In the inner ear,
besides the actin-rich areas, Rac1 is localized to hair
cells and in particular, the kinocilium [37]. In accordance
with our data, Arhgap12, at P0, with expression in the
hair cells and kinocilium, might be regulating by Rac1 at
this time, when the hair bundle is still developing and
needs to be under close regulation. The kinocilium is ne-
cessary for proper development [40] and may have a
structural role in guiding the architecture of the hair bun-
dle and/or be involved in G-protein signaling in the kino-
cilium. If the latter is true, then Arhgap12 may regulate its
GTPase activity. In our model of the miR-6715-3p circuit
in the inner ear, we propose that the miRNA indirectly en-
hances the action of Rac1 and therefore may promote hair
bundle development, actin reorganization, cell adhesion
and inner ear morphogenesis.
Conclusions
The identification of inner ear-related miRNAs by RNA-
seq analysis demonstrates that the dataset is reliable not
only for characterizing expression profiles of known
miRNAs, but also for discovery of novel miRNAs in the
inner ear. Further investigation of these miRNAs may
shed light on their regulatory roles in various molecular




All procedures involving animals were approved and
met the guidelines described in the National Institutes of
Health Guide for the Use of Laboratory Animals and
Figure 7 Arhgap12 protein expression in mouse inner ear whole-mount preparations. Immunohistochemistry of Arhgap12 (green) in
whole mount preparations of P0 mouse cochleas, with cell junctions stained by ZO-1 (red) and actin stained by phalloidin (blue). A. Arhgap12 is
localized to the hair and supporting cells of the sensory epithelium. B. In a higher magnification of A, Arhgap12 is localized to the hair bundle
and the kinocilium. C. Additional plane showing mutual exclusion of localization of Arhagp12 and ZO-1. hc, hair cells. Bar: A, 10 μm; B, 5 μm.
Figure 8 A newly identified miRNA-target regulatory pathway in the inner ear. A suggested pathway for miR-6715-3p and Arhgap12,
whereby miR-6715-3p down-regulates expression of Arhgap12, which in turn blocks the hydrolysis of Rac1 (Ras-Related C3 Botulinum Toxin
Substrate 1) GTPase. This may result in increased cell adhesion, actin reorganization and inner ear morphogenesis.
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Tel Aviv University (M-10-087). Cochlear and vestibular
sensory epithelia were dissected from 12 inner ears of 6
P0 C57Bl/6 J mice. The cochlear sensory epithelia in-
cluded the organ of Corti with some attached membranes,
while the vestibular sensory epithelia included the saccule,
utricle, lateral crista and anterior crista. The dissected sen-
sory epithelia were placed immediately in Qiazol lysis buf-
fer (Qiagen) on ice and stored at −80°C for several hours.
The sensory epithelia was then thawed and total RNA
was isolated, using the miRNeasy Mini Kit (Qiagen) with-
out DNAse, which enables purification of total RNA
of >18 nt. The isolated RNAs from the samples were pre-
cipitated in sodium acetate and glycogen in 80% ethanol
(Ambion protocol), in order to further clean and concen-
trate the RNA samples. The precipitated RNA samples
were dissolved in nuclease-free water and their quality
was assessed by 1.2% agarose gel (90 V).RNA-sequencing
Twelve cochlear epithelia were pooled and twelve vestibu-
lar epithelia were pooled, and each pool was used to create
a library for MPS and sequenced. No biological repeats
were performed. miRNA libraries for MPS were created
using the TruSeq SmallRNA SamplePrep Kit (Illumina),
with one modification. Instead of running the samples on
acrylamide gel in order to isolate the miRNA band, the
samples were loaded on a 4% agarose E-Gel and the puri-
fication was performed with the Qiagen Kit. The libraries
were multiplexed and 2.5 pM of each library was sequenced
at SR × 36 bp using the Illumina Genome Analyzer IIx in
the same lane at the Functional Genomics Laboratory at
Tel Aviv University.miRNA sequence analysis
A total of 8,763,589 and 10,048,818 raw sequences of
small RNAs were found in the cochlear and vestibular
samples, respectively. Small RNA adapter sequences were
clipped using fastq-mcf (ea-utils: http://code.google.com/
p/ea-utils/), discarding sequences shorter than 16 nucleo-
tides and adapter dimers. Following adapter clipping,
8,340,741 and 9,441,679 reads remained. Differential ex-
pression of the resulting sequences was performed using
miRNAkey. Specifically, sequence alignment was performed
using Burrows-Wheeler Aligner (BWA) [41] against mouse
mature miRNA sequences (downloaded from miRBase
(Release 20: June 2013; http://www.mirbase.org/), while
allowing one mismatch between read and reference. The
read count for each read was normalized using the RPM
method. Differential expression was tested using chi-squared
proportion testing and corrected using the Bonferroni cor-
rection for multiple comparisons. Novel miRNA predic-
tion was performed using miRDeep2 [42].qRT-PCR
Cochlear sensory epithelia of E16, P0 and P8 C57BL/6
mice was dissected. Small RNAs were extracted using
the miRNeasy Mini Kit (QIAGEN). Custom-made probes,
designed by Applied Biosystems, were used to detect miR-
NAs. miRNAs and U6B RNA (endogenous control) were
reverse transcribed using the High Capacity cDNA Re-
verse Transcription Kit (Applied Biosystems). The qRT-
PCR reaction was conducted using the FastStart Universal
Probe Master (Roche) in the StepOne Plus qRT-PCR ma-
chine (Applied Biosystems). All miRNAs expression was
normalized to the expression of U6B. At each age, sensory
epithelia from 4–5 mice were pooled and five RT-PCR
experiments were performed.
In situ hybridization
Inner ears of P0 C57BL/6 mice were dissected and fixed
with 4% paraformaldehyde. Whole mount in situ
hybridization analysis was performed using the Exiqon
protocol. miRCURY LNA™ microRNA detection custom-
made probes, labeled with digoxygenin (DIG) (Exiqon),
were used for the detection of novel miRNAs. Probes were
hybridized with the tissue, 20-22°C below Tm of the
probe. Probes were detected with the anti-DIG-AP (al-
kaline phosphatase conjugated) antibody (Roche), and
the color reaction was developed using the NTB/BCIP
(Sigma). The ears were frozen and cryosectioned to 10-
18 μm sections and mounted. Images were taken using
the Zeiss Aviovert200 M microscope. Three experiments
were performed, and 3–5 ears were included in each
experiment.
miRNA target prediction
Target prediction for all miRNAs was predicted by Tar-
getScan Custom (Release 5.2; http://www.targetscan.org/
vert_50/seedmatch.html), TargetScanMouse (Release 5.2,
http://www.targetscan.org/mmu_50/) and/or miRanda
(http://www.microrna.org/microrna/home.do). Chosen po-
tential targets were compared to gene expression databases
(SHIELD; https://shield.hms.harvard.edu/) and known hear-
ing loss genes and loci (Hereditary Hearing Loss Home-
page, http://hereditaryhearingloss.org).
Luciferase assay
3’ UTRs of chosen potential targets were cloned into the
pGL3 luciferase reporter vector, downstream to the lucif-
erase reporter gene, creating the 3’UTR-wt-pGL3 vector.
The first three nucleotides of the miRNA binding site in
the 3’UTR were mutated by site directed mutagenesis,
creating the 3’UTR-mut-pGL3 vector. The miR-6715
miRNA expression vector was created by cloning the
genomic polycistronic miR-6715-3p and miR-6715-5p
into the miRvec expression vector (obtained as a gift from
Reuven Agami) [43]. HEK293T cells were transiently
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mut-pGL3, for each of the tested targets, together with
the corresponding miRNA expression vector and Renilla
expressing vector. The luciferase reporter assay was
performed 48 hours following transfection using the
Dual-Luciferase® Reporter assay system (Promega). Three
experiments were conducted, with duplicates.
Immunohistochemistry
Whole mount and paraffin sections of P0 C67/BL6 mouse
inner ear were prepared for staining as previously de-
scribed [44]. Myosin VI was used to stain hair cells,
phalloidin to stain actin and Draq5 to stain nuclei. The
following antibodies were used: goat-anti-Arhgap12 anti-
body (Santa Cruz), 1:100; mouse-anti-ZO-1 (Zymed),
1:100; rabbit-anti-myosin VI (Proteus BioSciences) 1:200;
and Draq5 1:600 (Abcam). Antibody specificity of Arh-
gap12 was assessed by a competition assay in HCT116
cells, with blocking by an Arhagap12 peptide (Santa Cruz)
(Additional file 6).
Statistics
For qRT-PCR and luciferase assays, the Student’s two-tailed
t test P values of less than 0.05 were considered to be statis-
tically significant and those of less than 0.005 were consid-
ered to be highly statistically significant. The data in the
figures are presented by mean + SEM. Differential expres-
sion of miRNAs between paired samples was measured
using a chi-squared statistic. P-values are calculated for
the null hypothesis of no differential expression between
the two samples. Final P-values were corrected using the
Bonferroni correction for multiple hypotheses testing [18].
Availability of supporting data
The RNA-seq data from this study is available in the
NCBI Sequence Read Archive (SRA) (http://www.ncbi.
nlm.nih.gov/sra), under accession number SRP043019.
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Additional file 1: Table S1. miRNAkey output table for cochlear vs.
vestibular miRNA differential expression. miRNA differential expression
analysis includes the read count, RPM, fold change and comparison
statistics for each miRNA transcript.
Additional file 2: Table S2. Predicted targets categorized by gene
ontology (GO) of biological-based processes.
Additional file 3: Table S3. Genes associated with “impaired hearing”
and “deafness” impairment in MGI.
Additional file 4: Table S4. Expression of pri-miRNAs found inside
introns of “impaired hearing” and “deafness” genes, as defined in MGI.
Additional file 5: Table S5. Predicted targets for miR-6715-3p and
miR-6715-5p. Source: TargetScanHuman Custom Release 5.2: June 2011.
Additional file 6. Specificity of the Arhgap12 antibody was tested
by a peptide competition assay. HCT116 cells were stained with an
Arhgap12 antibody and an Arhgap12 peptide. No staining of Arhgap12
was observed in the blocked cells. Bar: 25 μm.Competing interests
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